BRAND_ANALYSIS #ASTRAZENECA HEALTH & PHARMA #18 OF 26 IN HEALTH & PHARMA ALIGNED

AstraZeneca

· Public · Updated 23 Aug 2026 07:27 UTC
#828 of 1208 overall by tension · #18 of 26 in Health & Pharma
11 Aligned
The Balanced
Analysis

AstraZeneca's -0.40 sentiment is the COVID hangover: business (73) and cultural relevance (62) sustained by pharma necessity, but reputational damage from vaccine-rollout failures calcifying into skepticism. The gap widens as trust erodes.

IN THE NEWS (100 articles this week)
Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer - AstraZeneca
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review - WSJ
AstraZeneca suffers another setback as it halts volrustomig lung cancer trial - Reuters
Cultural Score
62 / 100
Business Score
73 / 100
TENSION▁▁▁▂▂▁▁▁▁▁▁▁▂▁
CULTURAL▅▅▅▆▆▆▆▆▅▅▅▅▅▅
BUSINESS▅▅▄▄▅▅▅▅▅▅▅▆▆▆
Loading...
Wikipedia Momentum 22/40
News Presence 40/35
Search InterestRedistributed to other dimensions
Stock Momentum 16/30
Market Position 22/25
Revenue Growth 19/25
Earnings Health 16/20
Avg Daily (7d)450
Avg Daily (90d)510
7d/90d Ratio0.88x
Price$165.98
30d Change-1.4%
Market Cap$257.4B
Profit Margin17.0%
AstraZeneca's tension is 11. Commerce outpacing culture. sociologyofcapitalism.com/brand/astrazeneca
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/astrazeneca.html" width="320" height="200" frameborder="0"></iframe>